19.03
전일 마감가:
$19.18
열려 있는:
$19.26
하루 거래량:
33,396
Relative Volume:
0.47
시가총액:
$931.20M
수익:
-
순이익/손실:
$-75.28M
주가수익비율:
-9.5355
EPS:
-1.9957
순현금흐름:
$-57.45M
1주 성능:
-2.96%
1개월 성능:
-2.81%
6개월 성능:
+55.22%
1년 성능:
+57.93%
Oculis Holding Ag Stock (OCS) Company Profile
OCS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
OCS
Oculis Holding Ag
|
19.03 | 931.20M | 0 | -75.28M | -57.45M | -1.9957 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Oculis Holding Ag Stock (OCS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-12-05 | 개시 | Chardan Capital Markets | Buy |
2023-10-05 | 개시 | Stifel | Buy |
2023-06-14 | 개시 | BofA Securities | Buy |
2023-06-12 | 개시 | H.C. Wainwright | Buy |
2023-06-08 | 개시 | Robert W. Baird | Outperform |
2023-05-10 | 개시 | Pareto | Buy |
2023-04-28 | 개시 | Wedbush | Outperform |
모두보기
Oculis Holding Ag 주식(OCS)의 최신 뉴스
Oculis Holding AG (NASDAQ:OCS) Short Interest Update - Defense World
Oculis Holding AG (NASDAQ:OCS) Short Interest Down 14.1% in February - Defense World
Oculis Publishes Notifications of Transactions by Person Discharging Managerial Responsibilities - MarketScreener
Insider Buying: Oculis Holding Independent Director Bought CHF326k Of Shares - simplywall.st
Lionel Carnot Spends CHF326k On Oculis Holding Stock - Yahoo Canada Finance
HC Wainwright Comments on Oculis’ Q1 Earnings (NASDAQ:OCS) - Defense World
Robert W. Baird Boosts Oculis (NASDAQ:OCS) Price Target to $41.00 - Defense World
HC Wainwright Lowers Oculis (NASDAQ:OCS) Price Target to $29.00 - Defense World
Oculis (NASDAQ:OCS) Sees Strong Trading Volume After Analyst Upgrade - Defense World
Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update - Informazione.it
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - Marketscreener.com
(OCS) Investment Analysis - Stock Traders Daily
Oculis Holding AG (OCS) Reports Q4 Loss, Misses Revenue Estimates - MSN
Stifel maintains Buy on Oculis shares, price target at $35 By Investing.com - Investing.com Australia
H.C. Wainwright cuts Oculis stock target to $29, keeps Buy rating - Investing.com Australia
H.C. Wainwright cuts Oculis stock target to $29, keeps Buy rating By Investing.com - Investing.com South Africa
Oculis Holding AG Faces Heightened Cybersecurity Risks Amid Geopolitical Tensions - TipRanks
Oculis price target raised to $32 from $31 at BofA - TipRanks
Oculis (NASDAQ:OCS) Shares Gap Down Following Weak Earnings - Defense World
Oculis Holding AG Reports 2024 Financial Results - TipRanks
Oculis Reports 2024 Fourth Quarter Net Loss, Completes $100 Million Equity Financing to Support Pipeline - Vision Monday
Stifel maintains Buy on Oculis shares, price target at $35 - Investing.com
Oculis Holding AG reports results for the quarter ended December 31Earnings Summary - TradingView
Oculis Holding AG Reports 2024 Financial Results and Clinical Progress - TipRanks
Oculis (OCS) Projected to Post Quarterly Earnings on Monday - Defense World
(OCSAW) On The My Stocks Page - news.stocktradersdaily.com
Oculis to Present at Upcoming March Investor Conference - The Manila Times
(OCS) Investment Report - Stock Traders Daily
(OCS) On The My Stocks Page - Stock Traders Daily
Oculis Holding AG (NASDAQ:OCS) Short Interest Down 68.6% in January - MarketBeat
Oculis (NASDAQ:OCS) Shares Down 7.2%Should You Sell? - MarketBeat
Oculis Holding AG Prices $100 Million Oversubscribed Share Offering - TipRanks
Oculis Holding Prices Offering of 5 Million Shares -February 14, 2025 at 04:36 am EST - Marketscreener.com
Biopharmaceutical Company Oculis Seeks $100 Million from Share Sale -February 14, 2025 at 12:56 am EST - Marketscreener.com
Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares - The Manila Times
Major Funding Breakthrough: Oculis Secures $100M for Revolutionary Eye Treatment Development - StockTitan
Oculis Raises Massive $100M War Chest: Major Pipeline Expansion for Revolutionary Eye Treatment - StockTitan
Oculis greinir frá umframeftirspurn og öðrum niðurstöðum 100 milljón USD útboðs á almennum hlutum - GlobeNewswire Inc.
Institutions along with retail investors who hold considerable shares inOculis Holding AG (NASDAQ:OCS) come under pressure; lose 8.9% of holdings value - Simply Wall St
(OCS) Trading Report - Stock Traders Daily
abrdn plc Buys 188,871 Shares of Oculis Holding AG (NASDAQ:OCS) - MarketBeat
Oculis (NASDAQ:OCS) Trading Down 0.2%Time to Sell? - MarketBeat
Insider Alert: Oculis Leadership Team Hits Major Share Vesting Milestone - StockTitan
Oculis Holding Ag (OCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):